Inventor · disambiguated record
Elfatih Elzein
Also filed as: ELZEIN ELFATIH · ELZEIN ELFATIH O
87 granted patents·30 pending applications·1,486 citations·filing 1999–2024
99Inventor score
Files withCV THERAPEUTICS INC46GILEAD SCIENCES INC19GILEAD PALO ALTO INC11TEON THERAPEUTICS INC10ZABLOCKI JEFF7
Top patents by PatentIndex Score
117 records- 0198US7144872B2N-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2005·Granted Dec 5, 2006·50 cites·27 claims
- 0297US7553823B2C-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2006·Granted Jun 30, 2009·48 cites·8 claims
- 0396US7732595B2Process for preparing an A2A-adenosine receptor agonist and its polymorphsGILEAD PALO ALTO INC·Filed 2007·Granted Jun 8, 2010·40 cites·13 claims
- 0496US7655637B2N-pyrazole A2A receptor agonistsGILEAD PALO ALTO INC·Filed 2006·Granted Feb 2, 2010·31 cites·19 claims
- 0596US7183264B2N-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2003·Granted Feb 27, 2007·48 cites·22 claims
- 0696US6825349B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2002·Granted Nov 30, 2004·95 cites·31 claims
- 0796US6642210B12-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Nov 4, 2003·61 cites·18 claims
- 0896US6552023B2Aralkyl substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Apr 22, 2003·64 cites·24 claims
- 0996US6403567B1N-pyrazole A2A adenosine receptor agonistsCV THERAPEUTICS INC·Filed 1999·Granted Jun 11, 2002·112 cites·13 claims
- 1095US7671192B2Process for preparing an A2A-adenosine receptor agonist and its polymorphsGILEAD PALO ALTO INC·Filed 2007·Granted Mar 2, 2010·37 cites·5 claims
- 1195US7625881B2Prodrugs of A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2006·Granted Dec 1, 2009·31 cites·17 claims
- 1295US7317017B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2005·Granted Jan 8, 2008·22 cites·15 claims
- 1395US7109180B2C-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2004·Granted Sep 19, 2006·43 cites·8 claims
- 1495US6770634B1C-pyrazole a2a receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Aug 3, 2004·46 cites·6 claims
- 1595US6677336B2Substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Jan 13, 2004·59 cites·34 claims
- 1695US6573264B1Heteroaryl alkyl piperazine derivativesCV THERAPEUTICS INC·Filed 2000·Granted Jun 3, 2003·60 cites·41 claims
- 1794US9371329B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2014·Granted Jun 21, 2016·26 cites·2 claims
- 1894US8952034B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2010·Granted Feb 10, 2015·29 cites·18 claims
- 1994US8586732B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Nov 19, 2013·29 cites·35 claims
- 2093US7956179B2Process for preparing an A2A-adenosine receptor agonist and its polymorphsGILEAD SCIENCES INC·Filed 2010·Granted Jun 7, 2011·18 cites·7 claims
- 2193US7741331B2A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Jun 22, 2010·16 cites·8 claims
- 2292US8697863B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Apr 15, 2014·13 cites·11 claims
- 2392US6451798B2Substituted alkyl piperazine derivativesCV THERAPEUTICS INC·Filed 2001·Granted Sep 17, 2002·26 cites·26 claims
- 2492US6214807B1C-pyrazole 2A A receptor agonistsCV THERAPEUTICS INC·Filed 1999·Granted Apr 10, 2001·74 cites·33 claims
- 2591US9676760B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 13, 2017·7 cites·2 claims
- 2691US9598435B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 21, 2017·9 cites·13 claims
- 2791US7125993B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Oct 24, 2006·37 cites·47 claims
- 2891US6946449B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2002·Granted Sep 20, 2005·26 cites·30 claims
- 2991US6855818B2C-pyrazole A2A receptor agonistsCV THERAEPUTICS INC·Filed 2001·Granted Feb 15, 2005·45 cites·1 claims
- 3090US9193694B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Nov 24, 2015·11 cites·11 claims
- 3190US8268988B2Process for preparing an A2A-adenosine receptor agonist and its polymorphsZABLOCKI JEFF·Filed 2011·Granted Sep 18, 2012·10 cites·16 claims
- 3290US7795269B2A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Sep 14, 2010·8 cites·14 claims
- 3389US8389500B2Fused heterocyclic compounds as ion channel modulatorsABELMAN MATTHEW·Filed 2009·Granted Mar 5, 2013·16 cites·24 claims
- 3489US8278435B2N-pyrazole A2A receptor agonistsZABLOCKI JEFF A·Filed 2010·Granted Oct 2, 2012·9 cites·14 claims
- 3588US7713946B2Partial and full agonists A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2006·Granted May 11, 2010·12 cites·19 claims
- 3687US11564928B1Cannabinoid receptor type 2 (CB2) modulators and uses thereofTEON THERAPEUTICS INC·Filed 2022·Granted Jan 31, 2023·1 cites·19 claims
- 3787US8524883B2Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamideZABLOCKI JEFF·Filed 2011·Granted Sep 3, 2013·8 cites·5 claims
- 3887US7521554B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2006·Granted Apr 21, 2009·7 cites·5 claims
- 3986US7304070B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Dec 4, 2007·23 cites·36 claims
- 4085US7271157B2A1 adenosine receptor agonistsCV THERAPEUTICS INC·Filed 2005·Granted Sep 18, 2007·7 cites·29 claims
- 4184US9403782B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Aug 2, 2016·4 cites·10 claims
- 4284US9085601B2Process for preparing an A2A-adenosine receptor agonist and its polymorphsGILEAD SCIENCES INC·Filed 2013·Granted Jul 21, 2015·4 cites·5 claims
- 4384US8569260B2N-pyrazole A2A receptor agonistsZABLOCKI JEFF A·Filed 2012·Granted Oct 29, 2013·4 cites·10 claims
- 4484US8324224B2A2B adenosine receptor antagonistsKALLA RAO·Filed 2011·Granted Dec 4, 2012·5 cites·8 claims
- 4584US6677343B2Substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Jan 13, 2004·15 cites·25 claims
- 4684US6440948B1Thiophene A2A receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Aug 27, 2002·19 cites·16 claims
- 4783USRE47301EProcess for preparing an A2A-adenosine receptor agonist and its polymorphsGILEAD SCIENCES INC·Filed 2017·Granted Mar 19, 2019·1 cites·17 claims
- 4883US8158810B2ALDH-2 inhibitors in the treatment of addictionZABLOCKI JEFF·Filed 2009·Granted Apr 17, 2012·7 cites·11 claims
- 4982US11040033B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2018·Granted Jun 22, 2021·1 cites·22 claims
- 5082US9045519B2N-pyrazole A2A receptor agonistsGILEAD SCIENCES INC·Filed 2013·Granted Jun 2, 2015·2 cites·13 claims
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Elfatih Elzein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →